Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $676.92 billion, securing the top spot among global Pharmaceuticals companies. Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ) follow closely behind. The data was last updated on January 22, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
201
|
 Akero Therapeutics
AKRO
|
$1.75 B | $25.13 |
-12.0%
|
12.1%
|
United States
|
|
202
|
 Amphastar Pharmaceuticals
AMPH
|
$1.73 B | $36.01 |
-6.7%
|
-35.6%
|
United States
|
|
203
|
 Wave Life Sciences
WVE
|
$1.72 B | $11.29 |
-17.2%
|
142.9%
|
Singapore
|
|
204
|
 Jubilant Pharmova
JUBLPHARMA.NS
|
$1.72 B | $10.85 |
-10.0%
|
70.4%
|
India
|
|
205
|
 Disc Medicine
IRON
|
$1.72 B | $57.76 |
-10.4%
|
-11.7%
|
United States
|
|
206
|
 MannKind Corp
MNKD
|
$1.67 B | $6.05 |
-10.8%
|
74.2%
|
United States
|
|
207
|
 Granules India
GRANULES.NS
|
$1.66 B | $6.83 |
-1.6%
|
40.4%
|
India
|
|
208
|
 Travere Therapeutics
TVTX
|
$1.65 B | $18.92 |
7.2%
|
97.7%
|
United States
|
|
209
|
 Dynavax Technologies
DVAX
|
$1.64 B | $12.51 |
-3.0%
|
-12.7%
|
United States
|
|
210
|
 Structure Therapeutics
GPCR
|
$1.63 B | $28.52 |
-4.2%
|
-34.6%
|
United States
|
|
211
|
 Nippon Shinyaku
4516.T
|
$1.63 B | $24.19 |
-4.3%
|
-25.8%
|
Japan
|
|
212
|
 Taro Pharmaceutical
TARO
|
$1.62 B | $42.97 |
0.00%
|
2.1%
|
Israel
|
|
213
|
 Celldex Therapeutics
CLDX
|
$1.61 B | $24.27 |
-5.4%
|
-38.4%
|
United States
|
|
214
|
 Arcutis Biotherapeutics
ARQT
|
$1.58 B | $13.50 |
-15.4%
|
202.6%
|
United States
|
|
215
|
 Galapagos NV
GLPG
|
$1.58 B | $23.95 |
-12.4%
|
-37.6%
|
Belgium
|
|
216
|
 BioCryst Pharmaceuticals
BCRX
|
$1.55 B | $7.49 |
-2.9%
|
35.5%
|
United States
|
|
217
|
 Immunocore
IMCR
|
$1.51 B | $30.16 |
-0.35%
|
-60.4%
|
United Kingdom
|
|
218
|
 Indivior PLC
INDV
|
$1.50 B | $12.04 |
-2.8%
|
-33.1%
|
United States
|
|
219
|
 Praxis Precision Medicines
PRAX
|
$1.49 B | $79.85 |
-8.7%
|
83.6%
|
United States
|
|
220
|
 Pharma Mar
PHM.MC
|
$1.47 B | $84.93 |
2.6%
|
109.5%
|
Spain
|
|
221
|
 Evotec
EVO
|
$1.47 B | $4.14 |
-17.4%
|
-49.9%
|
Germany
|
|
222
|
 Dyne Therapeutics
DYN
|
$1.45 B | $14.26 |
-41.1%
|
-16.8%
|
United States
|
|
223
|
 Sumitomo Pharma
4506.T
|
$1.44 B | $3.63 |
-3.9%
|
18.3%
|
Japan
|
|
224
|
 Sanofi India Limited
SANOFI.NS
|
$1.44 B | $62.42 |
-8.7%
|
-32.7%
|
India
|
|
225
|
 Viridian Therapeutics
VRDN
|
$1.43 B | $18.10 |
-6.1%
|
-4.3%
|
United States
|
|
226
|
 Biotest
BIO.F
|
$1.43 B | $42.73 |
0.00%
|
-1.9%
|
Germany
|
|
227
|
 Novavax
NVAX
|
$1.42 B | $8.89 |
-1.3%
|
97.2%
|
United States
|
|
228
|
 Gubra A/S
GUBRA.CO
|
$1.42 B | $87.14 |
-0.95%
|
447.4%
|
Denmark
|
|
229
|
 Maravai LifeSciences
MRVI
|
$1.42 B | $5.61 |
-10.5%
|
-24.3%
|
United States
|
|
230
|
 Xencor
XNCR
|
$1.41 B | $20.10 |
-20.8%
|
-2.5%
|
United States
|
|
231
|
 Nurix Therapeutics
NRIX
|
$1.38 B | $19.52 |
-2.2%
|
139.0%
|
United States
|
|
232
|
 Fagron
FAGR.BR
|
$1.37 B | $18.82 |
8.4%
|
9.0%
|
Belgium
|
|
233
|
 Hanmi Pharmaceutical
008930.KS
|
$1.36 B | $20.06 |
-2.4%
|
-27.7%
|
South Korea
|
|
234
|
 Genomma Lab Internacional SAB de CV
LABB.MX
|
$1.33 B | $1.33 |
7.9%
|
108.1%
|
Mexico
|
|
235
|
 Kiniksa Pharmaceuticals
KNSA
|
$1.34 B | $18.53 |
-6.2%
|
0.16%
|
|
|
236
|
 Marksans Pharma
MARKSANS.NS
|
$1.32 B | $2.92 |
-11.1%
|
75.8%
|
India
|
|
237
|
 Spyre Therapeutics
SYRE
|
$1.31 B | $21.75 |
-11.7%
|
-24.7%
|
United States
|
|
238
|
 ARS Pharmaceuticals
SPRY
|
$1.31 B | $13.49 |
10.2%
|
85.7%
|
United States
|
|
239
|
 Harrow Health
HROW
|
$1.25 B | $35.05 |
0.06%
|
240.9%
|
United States
|
|
240
|
 Ocular Therapeutix
OCUL
|
$1.25 B | $7.92 |
-3.8%
|
93.5%
|
United States
|
|
241
|
 Arvinas
ARVN
|
$1.23 B | $17.95 |
-3.6%
|
-50.4%
|
United States
|
|
242
|
 Day One Biopharmaceuticals
DAWN
|
$1.23 B | $12.20 |
-1.0%
|
-8.8%
|
United States
|
|
243
|
 ANI Pharmaceuticals
ANIP
|
$1.21 B | $57.78 |
7.9%
|
3.2%
|
United States
|
|
244
|
 Adaptive Biotechnologies
ADPT
|
$1.20 B | $8.14 |
6.6%
|
55.8%
|
United States
|
|
245
|
 Syndax Pharmaceuticals
SNDX
|
$1.19 B | $13.94 |
0.08%
|
-38.4%
|
United States
|
|
246
|
 Ardelyx
ARDX
|
$1.19 B | $5.01 |
8.0%
|
-42.1%
|
United States
|
|
247
|
 Innoviva
INVA
|
$1.17 B | $18.70 |
4.5%
|
11.5%
|
United States
|
|
248
|
 Liquidia Technologies
LQDA
|
$1.17 B | $13.81 |
11.8%
|
5.2%
|
United States
|
|
249
|
 Cosmo Pharmaceuticals
C43.F
|
$1.17 B | $71.90 |
4.5%
|
9.2%
|
Ireland
|
|
250
|
 Faes Farma
FAE.MC
|
$1.11 B | $3.57 |
0.89%
|
15.9%
|
Spain
|
|
251
|
 SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation)
2070.SR
|
$1.10 B | $9.22 |
7.9%
|
-9.6%
|
Saudi Arabia
|
|
252
|
 Aurinia Pharmaceuticals
AUPH
|
$1.10 B | $7.71 |
-13.9%
|
-4.0%
|
Canada
|
|
253
|
 Calliditas Therapeutics
CALT
|
$1.10 B | $40.00 |
0.00%
|
71.5%
|
Sweden
|
|
254
|
 Enliven Therapeutics
ELVN
|
$1.09 B | $22.33 |
-7.3%
|
42.1%
|
United States
|
|
255
|
 Rocket Pharmaceuticals
RCKT
|
$1.08 B | $10.17 |
-11.7%
|
-63.5%
|
United States
|
|
256
|
 Tilray
TLRY
|
$1.07 B | $1.14 |
-17.0%
|
-42.4%
|
Canada
|
|
257
|
 Collegium Pharmaceutical
COLL
|
$1.06 B | $33.01 |
14.8%
|
1.2%
|
United States
|
|
258
|
 AbCellera
ABCL
|
$1.05 B | $3.54 |
3.7%
|
-42.4%
|
Canada
|
|
259
|
 Intellia Therapeutics
NTLA
|
$1.03 B | $10.12 |
-21.2%
|
-63.2%
|
United States
|
|
260
|
 Pharvaris
PHVS
|
$1.02 B | $18.74 |
1.5%
|
-35.3%
|
Netherlands
|
|
261
|
 PolyPeptide Group
PPGN.SW
|
$0.99 B | $30.14 |
-8.3%
|
71.9%
|
Switzerland
|
|
262
|
 Zymeworks
ZYME
|
$0.98 B | $14.30 |
1.1%
|
39.0%
|
Canada
|
|
263
|
 Replimune
REPL
|
$0.97 B | $12.56 |
-18.9%
|
29.0%
|
United States
|
|
264
|
 Oculis Holding AG
OCS
|
$0.95 B | $22.73 |
33.3%
|
104.9%
|
Switzerland
|
|
265
|
 Poseida Therapeutics
PSTX
|
$0.93 B | $9.50 |
0.11%
|
197.8%
|
United States
|
|
266
|
 Gyre Therapeutics
GYRE
|
$0.91 B | $10.66 |
-8.0%
|
-32.2%
|
United States
|
|
267
|
 Cogent Biosciences
COGT
|
$0.90 B | $8.19 |
2.2%
|
73.4%
|
United States
|
|
268
|
 Nuvation Bio
NUVB
|
$0.90 B | $2.67 |
-11.0%
|
51.2%
|
United States
|
|
269
|
 Evolus
EOLS
|
$0.90 B | $14.17 |
-3.1%
|
-10.6%
|
United States
|
|
270
|
 ArriVent BioPharma
AVBP
|
$0.90 B | $26.58 |
-8.3%
|
22.0%
|
United States
|
|
271
|
 Bicycle Therapeutics
BCYC
|
$0.88 B | $12.79 |
0.82%
|
-16.4%
|
United Kingdom
|
|
272
|
 Curevac
CVAC
|
$0.88 B | $3.92 |
38.5%
|
12.2%
|
Germany
|
|
273
|
 FDC India
FDC.NS
|
$0.88 B | $5.39 |
-4.6%
|
14.6%
|
India
|
|
274
|
 Vetoquinol
VETO.PA
|
$0.83 B | $69.40 |
-2.3%
|
-30.8%
|
France
|
|
275
|
 Anavex Life Sciences
AVXL
|
$0.82 B | $9.71 |
-15.3%
|
39.5%
|
United States
|
|
276
|
 Relay Therapeutics
RLAY
|
$0.81 B | $4.83 |
5.4%
|
-55.4%
|
United States
|
|
277
|
 Tyra Biosciences
TYRA
|
$0.80 B | $15.89 |
14.9%
|
21.1%
|
United States
|
|
278
|
 Avid Bioservices
CDMO
|
$0.80 B | $12.45 |
1.1%
|
84.4%
|
United States
|
|
279
|
 uniQure
QURE
|
$0.79 B | $14.81 |
-14.1%
|
154.7%
|
Netherlands
|
|
280
|
 89bio
ETNB
|
$0.78 B | $6.62 |
-20.5%
|
-42.5%
|
United States
|
|
281
|
 Sana Biotechnology
SANA
|
$0.78 B | $3.48 |
80.6%
|
-40.9%
|
United States
|
|
282
|
 Prothena
PRTA
|
$0.77 B | $14.32 |
-8.4%
|
-58.1%
|
Ireland
|
|
283
|
 Avadel Pharmaceuticals
AVDL
|
$0.75 B | $7.79 |
-22.8%
|
-44.2%
|
Ireland
|
|
284
|
 Cormedix
CRMD
|
$0.74 B | $12.19 |
46.1%
|
271.0%
|
United States
|
|
285
|
 Ginkgo Bioworks
DNA
|
$0.71 B | $12.40 |
15.6%
|
-78.7%
|
United States
|
|
286
|
 Opthea
OPT
|
$0.69 B | $4.47 |
21.5%
|
63.9%
|
Australia
|
|
287
|
 ORIC Pharmaceuticals
ORIC
|
$0.69 B | $9.76 |
17.0%
|
-11.5%
|
United States
|
|
288
|
 LENZ Therapeutics
LENZ
|
$0.68 B | $24.62 |
-28.6%
|
439.6%
|
United States
|
|
289
|
 Pliant Therapeutics
PLRX
|
$0.67 B | $10.97 |
-16.9%
|
-35.7%
|
United States
|
|
290
|
 SPARC
SPARC.NS
|
$0.66 B | $2.03 |
-9.9%
|
-52.3%
|
India
|
|
291
|
 Immatics
IMTX
|
$0.64 B | $5.29 |
-23.9%
|
-53.4%
|
Germany
|
|
292
|
 Capricor Therapeutics
CAPR
|
$0.64 B | $14.12 |
-2.2%
|
231.7%
|
United States
|
|
293
|
 Exscientia
EXAI
|
$0.63 B | $4.84 |
0.00%
|
-20.8%
|
United Kingdom
|
|
294
|
 Pharming Group
PHAR
|
$0.63 B | $9.28 |
-9.5%
|
-20.4%
|
Netherlands
|
|
295
|
 Strides Pharma
STAR.NS
|
$0.62 B | $6.73 |
-7.9%
|
-6.9%
|
India
|
|
296
|
 Immunome
IMNM
|
$0.62 B | $9.91 |
-9.3%
|
-33.4%
|
United States
|
|
297
|
 Arbutus Biopharma
ABUS
|
$0.60 B | $3.18 |
0.63%
|
33.3%
|
United States
|
|
298
|
 Cullinan Therapeutics
CGEM
|
$0.60 B | $10.34 |
-16.4%
|
-17.9%
|
United States
|
|
299
|
 Tectonic Therapeutic
TECX
|
$0.60 B | $40.54 |
-19.1%
|
156.3%
|
United States
|
|
300
|
 Ironwood Pharmaceuticals
IRWD
|
$0.60 B | $3.73 |
-20.6%
|
-72.8%
|
United States
|
|
301
|
 Verve Therapeutics
VERV
|
$0.59 B | $6.99 |
6.4%
|
-49.5%
|
United States
|
|
302
|
 CARGO Therapeutics
CRGX
|
$0.59 B | $12.85 |
-15.5%
|
-47.1%
|
United States
|
|
303
|
 Emergent BioSolutions
EBS
|
$0.58 B | $10.77 |
19.0%
|
401.5%
|
United States
|
|
304
|
 Kura Oncology
KURA
|
$0.58 B | $7.43 |
-18.1%
|
-45.9%
|
United States
|
|
305
|
 Autolus Therapeutics
AUTL
|
$0.56 B | $2.12 |
7.1%
|
-56.3%
|
United Kingdom
|
|
306
|
 EyePoint Pharmaceuticals
EYPT
|
$0.56 B | $8.23 |
2.0%
|
-70.0%
|
United States
|
|
307
|
 Erasca
ERAS
|
$0.54 B | $1.90 |
-28.0%
|
7.6%
|
United States
|
|
308
|
 KYORIN Pharmaceutical
4569.T
|
$0.53 B | $9.26 |
-0.62%
|
-16.7%
|
Japan
|
|
309
|
 MaxCyte
MXCT
|
$0.53 B | $5.01 |
20.2%
|
-3.3%
|
United States
|
|
310
|
 Akebia Therapeutics
AKBA
|
$0.52 B | $2.38 |
11.3%
|
47.9%
|
United States
|
|
311
|
 Omeros Corporation
OMER
|
$0.52 B | $8.94 |
-6.7%
|
173.6%
|
United States
|
|
312
|
 Stoke Therapeutics
STOK
|
$0.52 B | $9.77 |
-17.3%
|
89.9%
|
United States
|
|
313
|
 Hikal
HIKAL.NS
|
$0.52 B | $4.19 |
-1.0%
|
29.1%
|
India
|
|
314
|
 Mind Medicine
MNMD
|
$0.52 B | $7.03 |
-2.3%
|
90.3%
|
United States
|
|
315
|
 Sequent Scientific
SEQUENT.NS
|
$0.51 B | $2.05 |
3.5%
|
34.2%
|
India
|
|
316
|
 Mineralys Therapeutics
MLYS
|
$0.51 B | $10.30 |
-27.8%
|
-2.2%
|
United States
|
|
317
|
 AnaptysBio
ANAB
|
$0.50 B | $16.36 |
14.1%
|
-34.0%
|
United States
|
|
318
|
 Xeris Pharmaceuticals
XERS
|
$0.49 B | $3.31 |
-7.8%
|
31.7%
|
United States
|
|
319
|
 Entrada Therapeutics
TRDA
|
$0.49 B | $13.03 |
-27.7%
|
-20.9%
|
United States
|
|
320
|
 Rapport Therapeutics
RAPP
|
$0.49 B | $13.28 |
-31.3%
|
-39.0%
|
United States
|
|
321
|
 Altimmune
ALT
|
$0.48 B | $6.81 |
-9.1%
|
-31.5%
|
United States
|
|
322
|
 Cartesian Therapeutics
RNAC
|
$0.48 B | $18.70 |
4.4%
|
-17.4%
|
United States
|
|
323
|
 Boiron
BOI.PA
|
$0.48 B | $27.41 |
0.00%
|
-33.7%
|
France
|
|
324
|
 MeiraGTx
MGTX
|
$0.47 B | $6.07 |
1.5%
|
-5.3%
|
United States
|
|
325
|
 Absci
ABSI
|
$0.47 B | $4.11 |
-3.7%
|
-20.5%
|
United States
|
|
326
|
 Phathom Pharmaceuticals
PHAT
|
$0.47 B | $6.89 |
-7.2%
|
-1.7%
|
United States
|
|
327
|
 Arcturus Therapeutics
ARCT
|
$0.47 B | $17.37 |
1.6%
|
-51.5%
|
United States
|
|
328
|
 Savara Pharmaceuticals
SVRA
|
$0.47 B | $2.72 |
-8.4%
|
-42.0%
|
United States
|
|
329
|
 GH Research
GHRS
|
$0.47 B | $8.97 |
26.8%
|
47.1%
|
Ireland
|
|
330
|
 SIGA Technologies
SIGA
|
$0.45 B | $6.36 |
3.8%
|
32.7%
|
United States
|
|
331
|
 Keros Therapeutics
KROS
|
$0.45 B | $11.16 |
-35.0%
|
-80.5%
|
United States
|
|
332
|
 Mereo BioPharma Group
MREO
|
$0.45 B | $2.90 |
-1.3%
|
25.8%
|
United Kingdom
|
|
333
|
 Tourmaline Bio
TRML
|
$0.45 B | $17.53 |
-15.9%
|
-53.2%
|
United States
|
|
334
|
 ChromaDex
CDXC
|
$0.45 B | $5.87 |
9.2%
|
336.8%
|
United States
|
|
335
|
 Theravance Biopharma
TBPH
|
$0.45 B | $9.05 |
-7.1%
|
-7.9%
|
|
|
336
|
 Annexon
ANNX
|
$0.44 B | $4.14 |
-19.7%
|
-10.4%
|
United States
|
|
337
|
 Aarti Drugs
AARTIDRUGS.NS
|
$0.44 B | $4.82 |
-7.2%
|
-21.4%
|
India
|
|
338
|
 Zevra Therapeutics
ZVRA
|
$0.44 B | $8.18 |
-6.3%
|
35.5%
|
United States
|
|
339
|
 KalVista Pharmaceuticals
KALV
|
$0.43 B | $8.76 |
-5.3%
|
-33.7%
|
United States
|
|
340
|
 Kamada
KMDA
|
$0.43 B | $7.42 |
17.0%
|
25.8%
|
Israel
|
|
341
|
 Sage Therapeutics
SAGE
|
$0.43 B | $6.95 |
29.2%
|
-73.5%
|
United States
|
|
342
|
 UroGen Pharma
URGN
|
$0.42 B | $9.94 |
-5.1%
|
-32.0%
|
United States
|
|
343
|
 Kodiak Sciences
KOD
|
$0.41 B | $7.87 |
-27.4%
|
98.6%
|
United States
|
|
344
|
 Olema Pharmaceuticals
OLMA
|
$0.41 B | $5.55 |
-10.4%
|
-49.4%
|
United States
|
|
345
|
 Esperion Therapeutics
ESPR
|
$0.41 B | $2.09 |
-3.9%
|
3.8%
|
United States
|
|
346
|
 PureTech Health
PRTC
|
$0.41 B | $17.04 |
-12.1%
|
-28.6%
|
United States
|
|
347
|
 Codexis
CDXS
|
$0.41 B | $5.00 |
0.00%
|
67.2%
|
United States
|
|
348
|
 Abivax
ABVX
|
$0.40 B | $6.33 |
-16.1%
|
-46.6%
|
France
|
|
349
|
 RPG Life Sciences
RPGLIFE.NS
|
$0.40 B | $24.03 |
-3.9%
|
32.7%
|
India
|
|
350
|
 Allogene Therapeutics
ALLO
|
$0.40 B | $1.89 |
-12.9%
|
-43.3%
|
United States
|
|
351
|
 Aura Biosciences
AURA
|
$0.39 B | $7.88 |
-5.6%
|
1.7%
|
United States
|
|
352
|
 Alumis
ALMS
|
$0.39 B | $7.21 |
-4.7%
|
-42.4%
|
United States
|
|
353
|
 Terns Pharmaceuticals
TERN
|
$0.39 B | $4.59 |
-23.6%
|
-18.9%
|
United States
|
|
354
|
 OmniAb
OABI
|
$0.39 B | $3.21 |
-9.1%
|
-47.6%
|
United States
|
|
355
|
 Prime Medicine
PRME
|
$0.38 B | $2.91 |
4.7%
|
-56.3%
|
United States
|
|
356
|
 Revance Therapeutics
RVNC
|
$0.38 B | $3.65 |
19.5%
|
-39.0%
|
United States
|
|
357
|
 Rigel Pharmaceuticals
RIGL
|
$0.38 B | $21.65 |
22.4%
|
58.5%
|
United States
|
|
358
|
 Valneva SE
VALN
|
$0.38 B | $4.65 |
8.4%
|
-47.2%
|
France
|
|
359
|
 G1 Therapeutics
GTHX
|
$0.38 B | $7.15 |
0.00%
|
89.2%
|
United States
|
|
360
|
 REGENXBIO
RGNX
|
$0.37 B | $7.56 |
-0.41%
|
-48.1%
|
United States
|
|
361
|
 Shinpoong Pharm
019170.KS
|
$0.36 B | $7.40 |
5.3%
|
-11.6%
|
South Korea
|
|
362
|
 enGene
ENGN
|
$0.36 B | $7.04 |
10.3%
|
-3.5%
|
Canada
|
|
363
|
 Compass Therapeutics
CMPX
|
$0.35 B | $2.58 |
73.3%
|
80.6%
|
United States
|
|
364
|
 Korro Bio
KRRO
|
$0.35 B | $37.56 |
-14.5%
|
-13.9%
|
United States
|
|
365
|
 Corvus Pharmaceuticals
CRVS
|
$0.35 B | $5.42 |
2.2%
|
145.6%
|
United States
|
|
366
|
 Chimerix
CMRX
|
$0.34 B | $3.83 |
6.3%
|
281.7%
|
United States
|
|
367
|
 Monte Rosa Therapeutics
GLUE
|
$0.34 B | $5.56 |
-19.8%
|
0.80%
|
United States
|
|
368
|
 Neumora Therapeutics
NMRA
|
$0.34 B | $2.09 |
-80.7%
|
-87.4%
|
United States
|
|
369
|
 Precigen
PGEN
|
$0.33 B | $1.12 |
40.5%
|
-21.3%
|
United States
|
|
370
|
 Trevi Therapeutics
TRVI
|
$0.33 B | $3.65 |
-6.0%
|
178.5%
|
United States
|
|
371
|
 Tango Therapeutics
TNGX
|
$0.33 B | $3.04 |
-6.3%
|
-74.9%
|
United States
|
|
372
|
 Medios AG
ILM1.DE
|
$0.32 B | $12.55 |
-5.5%
|
-17.9%
|
Germany
|
|
373
|
 XOMA
XOMA
|
$0.31 B | $26.59 |
-1.4%
|
35.5%
|
United States
|
|
374
|
 Taysha Gene Therapies
TSHA
|
$0.31 B | $1.52 |
-17.3%
|
2.0%
|
United States
|
|
375
|
 Euroapi
EAPI.PA
|
$0.31 B | $3.26 |
12.7%
|
-49.4%
|
France
|
|
376
|
 Indoco Remedies
INDOCO.NS
|
$0.31 B | $3.32 |
-2.0%
|
-12.1%
|
India
|
|
377
|
 Lexicon Pharmaceuticals
LXRX
|
$0.30 B | $0.84 |
-9.2%
|
-56.9%
|
United States
|
|
378
|
 Alimera Sciences
ALIM
|
$0.30 B | $5.54 |
0.00%
|
42.1%
|
United States
|
|
379
|
 Immutep
IMMP
|
$0.30 B | $1.96 |
-2.1%
|
-15.1%
|
Australia
|
|
380
|
 Contineum Therapeutics
CTNM
|
$0.30 B | $11.55 |
-13.7%
|
-19.2%
|
United States
|
|
381
|
 aTyr Pharma
ATYR
|
$0.30 B | $3.53 |
5.6%
|
134.4%
|
United States
|
|
382
|
 Aldeyra Therapeutics
ALDX
|
$0.29 B | $4.89 |
1.8%
|
57.7%
|
United States
|
|
383
|
 Aquestive Therapeutics
AQST
|
$0.29 B | $3.14 |
-11.9%
|
24.0%
|
United States
|
|
384
|
 Voyager Therapeutics
VYGR
|
$0.29 B | $5.24 |
-12.3%
|
-33.0%
|
United States
|
|
385
|
 iTeos Therapeutics
ITOS
|
$0.29 B | $7.83 |
7.1%
|
-21.8%
|
United States
|
|
386
|
 Design Therapeutics
DSGN
|
$0.28 B | $5.00 |
-20.3%
|
111.7%
|
United States
|
|
387
|
 Rezolute
RZLT
|
$0.28 B | $4.89 |
10.4%
|
377.5%
|
United States
|
|
388
|
 Amylyx Pharmaceuticals
AMLX
|
$0.28 B | $3.30 |
-10.0%
|
-75.4%
|
United States
|
|
389
|
 Y-mAbs Therapeutics
YMAB
|
$0.27 B | $6.12 |
-24.4%
|
-36.8%
|
United States
|
|
390
|
 Third Harmonic Bio
THRD
|
$0.27 B | $6.01 |
-43.9%
|
-39.5%
|
United States
|
|
391
|
 Aclaris Therapeutics
ACRS
|
$0.27 B | $2.52 |
-11.4%
|
100.8%
|
United States
|
|
392
|
 AC Immune
ACIU
|
$0.27 B | $2.71 |
-1.1%
|
-35.4%
|
Switzerland
|
|
393
|
 Atea Pharmaceuticals
AVIR
|
$0.27 B | $3.15 |
3.7%
|
-11.1%
|
United States
|
|
394
|
 C4 Therapeutics
CCCC
|
$0.26 B | $3.75 |
1.8%
|
-30.1%
|
United States
|
|
395
|
 Nautilus Biotechnology
NAUT
|
$0.26 B | $2.09 |
11.6%
|
-36.7%
|
United States
|
|
396
|
 DocMorris
DOCM.SW
|
$0.26 B | $22.10 |
-5.1%
|
-75.2%
|
Switzerland
|
|
397
|
 Vanda Pharmaceuticals
VNDA
|
$0.26 B | $4.45 |
-9.7%
|
17.5%
|
United States
|
|
398
|
 Silence Therapeutics
SLN
|
$0.25 B | $5.34 |
-19.9%
|
-70.2%
|
United Kingdom
|
|
399
|
 Benitec Biopharma
BNTC
|
$0.25 B | $10.82 |
-11.1%
|
256.2%
|
United States
|
|
400
|
 Eledon Pharmaceuticals
ELDN
|
$0.25 B | $4.19 |
-5.9%
|
136.5%
|
United States
|